MOAT ETF Is Down 7% in 2026. Here Is the Macro Signal That Changes Everything

Photo of Michael Williams
By Michael Williams Published

Quick Read

  • VanEck Morningstar Wide Moat ETF (MOAT) is down 7% year-to-date despite 259% gains over the past decade, with performance vulnerable to 10-year Treasury yields currently at 4.33%. Top holdings United Parcel Service (UPS) faces a restructuring inflection point with $3 billion in planned savings, Bristol Myers Squibb (BMY) carries $49.7 billion in debt with an FDA decision on iberdomide in August 2026, and Fortinet (FTNT) posted record free cash flow of $2.21 billion in 2025 while trading below its 52-week high.

  • Rising 10-year yields compress the present value of long-duration cash flows that MOAT’s quality-focused portfolio depends on, while quarterly reconstitution based on Morningstar’s fair value estimates could trigger exits for UPS, Bristol Myers Squibb, and other holdings that outperform.

  • Are you ahead, or behind on retirement? SmartAsset's free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don't waste another minute; learn more here.(Sponsor)

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
MOAT ETF Is Down 7% in 2026. Here Is the Macro Signal That Changes Everything

© Belarusian tourist landmark attraction Nesvizh Castle - medieval castle in autumn. Nesvizh, Belarus (Shutterstock.com) by Dmitry Rukhlenko

VanEck Morningstar Wide Moat ETF (NYSEARCA:MOAT) is down about 7% so far in 2026, yet it has returned roughly 9% over the past year and 259% over the past decade. Near-term pressure against a durable long-term record is exactly what this fund is built to navigate.

MOAT owns companies with wide economic moats (durable competitive advantages that competitors struggle to replicate) but only when Morningstar’s analysts believe those companies are trading below fair value. The result is a quality-at-a-discount portfolio that currently holds 51 positions across industrials, technology, and healthcare, with no exposure to utilities, energy, or real estate. At $13 billion in assets and a 0.46% expense ratio, it is one of the more established quality-focused ETFs available to individual investors.

The Rate Environment Will Define the Next 12 Months

MOAT’s core thesis depends on valuing long-duration cash flows from competitively entrenched businesses. That makes the 10-year Treasury yield the single most important macro variable to watch. When yields rise, the discount rate applied to future earnings rises with it, compressing the present value of every holding in the fund.

The 10-year yield currently sits at 4.33%, up 30 basis points from its February low of 3.97%. That recovery has coincided almost exactly with MOAT’s 9% one-month pullback. Several top holdings carry heavy debt loads, and both United Parcel Service (NYSE:UPS | UPS Price Prediction) and Huntington Ingalls Industries (NYSE:HII) operate with notable debt obligations on their balance sheets.

The VIX adds texture. At roughly 25, it sits in the 90th percentile of its one-year range, reflecting genuine uncertainty rather than routine volatility. Trade policy risk and tariff exposure flagged by multiple MOAT holdings are contributing. If the Fed signals rate cuts before mid-year or the 10-year yield retreats toward 4%, MOAT’s valuation math improves materially. The Federal Reserve’s FRED database tracks the 10-year yield in real time, and each FOMC meeting carries potential for guidance that could shift the rate trajectory.

Quarterly Reconstitution Is Where the Real Action Happens

MOAT rebalances quarterly based on Morningstar’s fair value estimates. When a stock rises above assessed fair value, it exits the index. When it falls back below, it can re-enter. This mechanism separates MOAT from a simple quality screen and is the micro factor most likely to drive performance divergence over the next year.

Bristol Myers Squibb (NYSE:BMY), the fund’s second-largest position at 3.1% weight, trades at a forward P/E near 9x with an FDA priority review decision on iberdomide expected in August 2026. Bristol Myers Squibb carries approximately $49.7 billion in outstanding debt. A positive outcome could push the stock above Morningstar’s fair value estimate and trigger an exit at the next rebalance, removing a 4.2%-yielding income contributor (the stock yields about 4.2%) from the portfolio.

UPS faces a similar dynamic. Management called 2026 “an inflection point in the execution of our strategy to deliver growth and sustained margin expansion” following the completion of its Amazon volume reduction. If the restructuring delivers on its $3 billion in additional planned savings and the stock re-rates toward the analyst consensus target of $113, it could cross Morningstar’s fair value threshold and rotate out.

Fortinet (NASDAQ:FTNT) represents the opposite scenario. The cybersecurity firm posted record free cash flow of $2.21 billion in 2025 and guided for revenue of $7.5 billion to $7.7 billion in 2026, yet the stock remains well below its 52-week high. If valuation stays compressed relative to Morningstar’s estimate, Fortinet stays in the fund and continues contributing.

VanEck publishes updated holdings after each quarterly rebalance (typically in March, June, September, and December), and Morningstar moat rating downgrades are the clearest signal that a stock faces a permanent exit rather than a valuation-driven rotation.

Photo of Michael Williams
About the Author Michael Williams →

I am a long time investor and student of business, and believe finding good companies that can become great investments is the best game on earth. After 20 years of writing and researching the public markets it is clear that individuals have never had more tools and information to take control of their financial lives. From ETFs and $0 commissions to cryptos and prediction markets there has never been a greater democratization of access to investing. 

I write to help people understand the investments available to them so they can make the best choice for their portfolio, whether they're starting out or looking for income in retirement. 

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

SBAC Vol: 6,563,665
INTC Vol: 116,894,024
CCI Vol: 6,078,125
DASH Vol: 5,051,322
GLW Vol: 11,572,082

Top Losing Stocks

ENPH Vol: 6,441,768
TSLA Vol: 82,993,122
GE Vol: 5,322,694
LKQ
LKQ Vol: 4,320,256
SWK Vol: 2,144,540